NCT04096768

The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation

Combining Dexmedetomidine and Ketamine in Intensive Care Sedation: Efficacy and Safety

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 394 (estimated)
• Sponsor: Lebanese American University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to compare the use of dexmedetomidine + ketamine with dexmedetomidine + placebo for sedation in ICU patients in terms of safety and efficacy

Conditions

• ICU Patients
• Sedation

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	Comparing Dexmedetomidine + Ketamine versus Dexmedetomidine + Placebo for sedation in ICU patients
DRUG	Ketamine	Comparing Dexmedetomidine + Ketamine versus Dexmedetomidine + Placebo for sedation in ICU patients

Timeline

• Start date: 2019-09-16
• Primary completion: 2021-09-16
• Completion: 2021-12-30
• First posted: 2019-09-20
• Last updated: 2020-02-20

Locations

1 site across 1 country: Lebanon

Regulatory

• FDA-regulated drug study